Frequent pediatric emergency department use in infancy and early childhood

Whitney V Cabey1, Emily MacNeill, Lindsey N White

  • 1From the *Department of Emergency Medicine, University of Michigan Health Systems, Ann Arbor, MI; †Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC; ‡Department of Emergency Medicine, Georgetown University, Washington, DC; §Dickson Advanced Analytics Group, Carolinas Medical Center, Charlotte, NC; and ∥Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN.

Pediatric Emergency Care
|October 2, 2014
PubMed

Insights

Frequent pediatric emergency department (PED) use was defined as 5 or more visits within 36 months. Key factors included lack of a primary care physician and non-private insurance.

Area of Science:

  • Pediatric Emergency Medicine
  • Healthcare Access
  • Public Health

Background:

  • Pediatric emergency department (PED) utilization patterns in early childhood are not well-defined.
  • Understanding factors associated with high PED use is crucial for optimizing healthcare delivery.

Purpose of the Study:

  • To establish the threshold for frequent PED use in children under 36 months.
  • To identify demographic and clinical factors associated with frequent PED use.

Main Methods:

  • Cross-sectional study of 16,664 children with 41,912 PED visits within the first 36 months of life.
  • Frequent PED use defined as the 90th percentile (≥5 visits per patient).
  • Multivariate analysis to determine predictors of frequent PED use.

Main Results:

  • The threshold for frequent PED use was 5 or more visits, affecting 14% of patients.
  • Lack of a primary care physician (OR 6.03) and non-private insurance (OR 3.64) were strong predictors.
  • Low acuity visits and factors like race, ethnicity, and poverty-associated zip codes were also associated with frequent PED use.

Conclusions:

  • Frequent pediatric emergency department use is defined as over 5 visits within the first three years of life.
  • Targeted interventions are needed to ensure appropriate care settings for high-utilizing pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
398
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
998
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
542
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
924
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
394
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K